Anesketin 100 mg/ml Solution for Injection
Anesketin 100 mg/ml Solution for Injection
Authorised
- Ketamine hydrochloride
Product identification
Medicine name:
Anesketin 100 mg/ml Solution for Injection
Anesketin 100 mg/ml oplossing voor injectie voor honden, katten en paarden
Active substance:
- Ketamine hydrochloride
Target species:
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Ketamine hydrochloride115.40milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Horse
-
Milk1day
-
Meat and offal1day
-
- Dog
- Cat
-
Intravenous use
- Horse
-
Milk1day
-
Meat and offal1day
-
- Dog
- Cat
-
Subcutaneous use
- Horse
-
Milk1day
-
Meat and offal1day
-
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 50 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 5 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 30 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 25 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 20 ml, 1 vial in a cardboard box
- Clear colourless type I glass vials with bromobutyl rubber stoppers and aluminium caps filled with 10 ml, 1 vial in a cardboard box
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 111764
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0278/001
Concerned member states:
-
Belgium
-
Denmark
-
France
-
Germany
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 5/01/2023
Dutch (PDF)
Published on: 1/03/2023
How useful was this page?: